Conference Preview: CHEST Annual Meeting 2024

News
Article

This year’s meeting will take place from October 6 to 9 in Boston, Massachusetts.

The annual meeting of the American College of Chest Physicians, CHEST 2024, is set to kick off in just a few short days. The conference is being held October 6 to 9 at the Boston Convention and Exhibition Center in Boston, Massachusetts and will feature the latest in cutting-edge clinical education.

Conference Preview: CHEST Annual Meeting 2024 / SeanPavonePhoto - stock.adobe.com

Conference Preview: CHEST Annual Meeting 2024 / SeanPavonePhoto - stock.adobe.com

CHEST 2024 will feature over 300 educational sessions, 29.5 hours of CE credits and more than 600 faculty members ready to share their expertise over 4 days. The meeting will also include opportunities for hands-on experiences, such as pre-meeting master classes, real-world simulation sessions and innovative education games.

This year’s keynote speaker, Vanessa Kerry, MD, MSc, director of the Program in Global Public Policy at the Massachusetts General Hospital and Harvard Medical School and World Health Organization Special Envoy for Climate Change and Health, will discuss how climate change is impacting human health and health systems on Sunday, October 6 at 8 a.m.

Session Highlights

The sessions at CHEST 2024 will bring together experts in the biggest topics that are impacting patient care, including the role of AI in health care and medical education, new guidelines on biologics for severe asthma and therapeutics for advanced COPD.

Sunday, October 6 at 9:45 AM

New Horizon in COPD

In this session, Surya Bhatt, MD, Diego Maselli Caceres, MD, FCCP, Francesca Polverino, PhD, MD and Caroline Quill, MD, will review the role of omics in COPD care, discuss the evolving role of digital technology in COPD care, and summarize the current drug pipeline for the management of COPD.

Sunday, October 6 at 1:30 PM

Vaccination Challenges and Strategies for Viral Respiratory Infections in Adults

Patients who are hospitalized with viral respiratory infections are a common challenge for providers. Shekhar Ghamande, MBBS, MD, FCCP, Robert Jacobson, MD, Anachal Kapoor, MD, FCCP, and Marcos Restrepo, MSc, MD, FCCP, will discuss vaccination updates in RSC, COVID-19, and influenza and strategies to overcome vaccine hesitation.

Monday, October 7 at 1:00 PM

Asthma and COPD Section: Inequity in Access and Adherence to Biologics in Severe Asthma

For adult patients with poorly controlled, severe, persistent asthma, biologic therapies have drastically changed treatment modalities. Melanie Krongold, MD, will discuss in this session the social determinants associated with access and adherence to biologic medication use in the United states and future efforts to reduce limitations to accessing these medications.

Wednesday, October 9 at 3:30 PM

Evaluation and Treatment of Exercise Intolerance and Fatigue in Patients With Long COVID: Where Are We Now?

In this session, Matthew Durstenfeld, MAS, MD, Inderjit Singh, MD, FCCP, and William Stringer, MD, FCCP will discuss exercise intolerance and fatigue in long COVID, focusing on the multiple, potentially synergistic, immunologic, virologic, mitochondrial, and deconditioning etiologies. The talk will touch on the characteristic symptoms of long COVID and the role of noninvasive and invasive CPET.

Be sure to stay up to date with all our CHEST 2024 coverage here.

Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our free Drug Topics newsletter.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.